Currently out of the existing stock ratings of Vik Chopra, 31 are a HOLD (50%), 31 are a BUY (50%).

Vik Chopra

Work Performance Price Targets & Ratings Chart

Analyst Vik Chopra, currently employed at WELLS FARGO, carries an average stock price target met ratio of 62.83% that have a potential upside of 22.3% achieved within 108 days.

Vik Chopra’s has documented 124 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVST, Envista Holdings Corp at 06-Feb-2026.

Wall Street Analyst Vik Chopra

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for IART (INTEGRA LIFESCIENCES HOLDINGS) at 5/6/2024. The price target of $25 was fulfilled within 1 day with a profit of $1.86 (8.04%) receiving and performance score of 80.38.

Average potential price target upside

of $11.4 (8.04%) on MASI (MASIMO).
of $7.22 (10.92%) on GMED (GLOBUS MEDICAL).
of $7.05 (99.17%) on ATEC (ALPHATEC HOLDINGS).

ENOV Enovis Corp GMED Globus Medical MASI Masimo NUVA NuVasive HSIC Henry Schein CNMD CONMED IART Integra LifeSciences Holdings NPCE Neuropace NVST Envista Holdings Corp XRAY Dentsply Sirona SOLV Solventum Corp. ALGN Align Technology ATEC Alphatec Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vik Chopra (WELLS FARGO)